New hope for hard-to-treat breast cancer: triple-drug combo enters phase 3 trial

NCT ID NCT06889688

First seen May 12, 2026 · Last updated May 14, 2026 · Updated 2 times

Summary

This study tests whether a combination of three drugs (camrelizumab, apatinib, and eribulin) works better than standard chemotherapy for people with advanced triple-negative breast cancer. The trial involves 246 women aged 18 to 70 whose cancer has spread. The goal is to see if the new combo can slow tumor growth and help people live longer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE IV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Changhai Hospital of Shanghai

    RECRUITING

    Shanghai, China

    Contact Phone: •••-•••-••••

  • Sun Yat-sen Memorial Hospital

    RECRUITING

    Guangzhou, Guangdong, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Affiliated Hospital of Guizhou Medical University

    RECRUITING

    Guiyang, Guizhou, China

    Contact

    Contact Phone: •••-•••-••••

  • The Central Hospital Of Yong Zhou

    RECRUITING

    Yongzhou, Hunan, China

    Contact Phone: •••-•••-••••

    Contact

  • Wuhan Union Hospital of China

    NOT_YET_RECRUITING

    Wuhan, Hubei, China

    Contact

    Contact Phone: •••-•••-••••

  • Xiangya Hospital of Central South University

    NOT_YET_RECRUITING

    Changsha, Hunan, China

    Contact

    Contact Phone: •••-•••-••••

  • Yichang Central People's Hospital

    RECRUITING

    Yichang, Hubei, China

    Contact

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.